1. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n = 4532);Montopoli;Ann Oncol,2020
2. No evidence that androgen regulation of pulmonary TMPRSS2 explains sex-discordant COVID-19 outcomes;Baratchian;BioRxiv,2020
3. Androgen receptor and androgen-dependent gene expression in lung;Mikkonena;Mol Cell Endocrinol,2010
4. TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic;Leach;Research Square,2020
5. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy;Goren;Dermatol Ther,2020